Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. [Phase 2, Phase 3]

View source ↗

Summary

A multicenter Phase 2/3 study evaluating potential disease-modifying treatments for individuals at risk for or with dominantly inherited early-onset Alzheimer's…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Familial
• Dementia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimers Disease, Dementia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-09-22